DKK2 and breast carcinoma: In cardiomyocytes, DKK2 was also proven by our results to be the negative modulator of Wnt/β‐catenin signaling, and functioned as the intermediary in miR-221/222 regulating Wnt/β‐catenin, which were revealed in previous work of breast cancer [23].